title: Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
authors.affiliation: Department of Haematology, Imperial College Healthcare NHS Trust and Imperial College London, Hammersmith Hospital, 4th Floor, Commonwealth Building, Du Cane Road, London, W12 0NN, UK. Electronic address: d.arachchillage@imperial.ac.uk.
authors.forename: Deepa R J
authors.initials: DR
authors.lastname: Arachchillage
authors.affiliation: Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge CB2 0QQ, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Besser
authors.affiliation: Department of Haematology, Imperial College Healthcare NHS Trust and Imperial College London, Hammersmith Hospital, 4th Floor, Commonwealth Building, Du Cane Road, London, W12 0NN, UK.
authors.forename: Rhona
authors.initials: R
authors.lastname: Maclean
authors.affiliation: Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge CB2 0QQ, UK.
authors.forename: Trevor
authors.initials: T
authors.lastname: Baglin
authors.affiliation: Department of Haematology, Imperial College Healthcare NHS Trust and Imperial College London, Hammersmith Hospital, 4th Floor, Commonwealth Building, Du Cane Road, London, W12 0NN, UK.
authors.forename: Joost J
authors.initials: JJ
authors.lastname: van Veen
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D000069604:Dabigatran / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors / Q000627:therapeutic use; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D010875:Pipecolic Acids / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D012008:Recurrence; D000069552:Rivaroxaban / Q000627:therapeutic use*; D013449:Sulfonamides; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D010875:Pipecolic Acids; D011720:Pyrazoles; D011728:Pyridones; D013449:Sulfonamides; C522181:apixaban; D001120:Arginine; D000069552:Rivaroxaban; D000069604:Dabigatran; C031942:argatroban
keywords: Apixaban; Argatroban; Cancer; Dabigatran; Recurrent venous thrombosis; Rivaroxaban